UPDATE 1-FDA approves Pfizer's drug for advanced breast cancer
October 16, 2018 at 12:28 PM EDT
The U.S. Food and Drug Administration said https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm623540.htm?utm_campaign=Oncology%2010%2F16%2F18%20talazoparib&utm_medium=email&utm_source=Eloqua&elqTrackId=3d45c5bae09748aa82b26d0d48f2c15b&elq=98e4248d80d04ab2907cce369a7c5176&elqaid=5513&elqat=1&elqCampaignId=4429 on Tuesday it approved Pfizer Inc's drug for an advanced form of breast cancer tied to an inherited gene mutation.
